MicroPort CardioFlow Medtech Corporation (HKG:2160)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
1.060
-0.010 (-0.93%)
Jan 21, 2026, 4:08 PM HKT

MicroPort CardioFlow Medtech Company Description

MicroPort CardioFlow Medtech Corporation, a medical device company, engages in the research, development, and commercialization of transcatheter and surgical solutions for structural heart diseases in the People’s Republic of China and internationally.

The company engages in research and development, manufacture, and sale of medical devices in the field of left atrial appendage, and treating valvular heart diseases, as well as properties management.

It’s product portfolio includes transcatheter aortic valves, left atrial appendage closure, transcatheter mitral valves, transcatheter tricuspid valves, and surgical accessories, as well as procedural accessories; and VitaFlow, VitaFlow Liberty, VitaFlow Liberty Flex, Alwide Plus, AccuSniperTM, AnchorMan LAAC System, AnchorMan LAAA System, and various TAVI, TMV, TTV, and LAA products.

In addition, the company provides technical consultation and technical services for medical devices clinical trial.

MicroPort CardioFlow Medtech Corporation was founded in 2009 and is headquartered in Shanghai, China.

MicroPort CardioFlow Medtech Corporation
CountryCayman Islands
Founded2009
IndustryMedical Devices
SectorHealthcare
Employees430
CEORuinian Zhang

Contact Details

Address:
No. 1661 Zhangdong Road
Shanghai, 201203
China
Phone86 21 3895 4600
Websitecardioflowmedtech.com

Stock Details

Ticker Symbol2160
ExchangeHong Kong Stock Exchange
Fiscal YearJanuary - December
Reporting CurrencyCNY
ISIN NumberKYG6082P1054
SIC Code3841

Key Executives

NamePosition
Ruinian ZhangPresident, GM and Executive Director
Philippe WanstokDeputy President and Executive Director
Xiangmei LiJoint Company Secretary
Lok Yee Chan A.C.I.S., A.C.S.Joint Company Secretary